{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T19:57:55Z","timestamp":1791835075826,"version":"4.3.4"},"reference-count":140,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1124\/jpet.124.002237","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T11:35:11Z","timestamp":1726486511000},"page":"100026","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Evaluating the potential for psilocybin as a treatment for post-traumatic stress disorder"],"prefix":"10.1016","volume":"392","author":[{"given":"Claire E.","family":"Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9967-9145","authenticated-orcid":false,"given":"Phillip R.","family":"Zoladz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.124.002237_bib1","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1007\/s00213-022-06123-7","article-title":"Great expectations: recommendations for improving the methodological rigor of psychedelic clinical trials","volume":"239","author":"Aday","year":"2022","journal-title":"Psychopharmacology"},{"key":"10.1124\/jpet.124.002237_bib2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/0269881119897615","article-title":"Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer","volume":"34","author":"Agin-Liebes","year":"2020","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1124\/jpet.124.002237_bib3","article-title":"Are there effective psychopharmacologic treatments for PTSD?","volume":"80","author":"Akiki","year":"2019","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1124\/jpet.124.002237_bib4","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2013"},{"key":"10.1124\/jpet.124.002237_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100538","article-title":"Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: an open-label safety and feasibility pilot study","volume":"27","author":"Anderson","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1124\/jpet.124.002237_bib6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41386-022-01370-w","article-title":"Synaptic plasticity and mental health: methods, challenges and opportunities","volume":"48","author":"Appelbaum","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.124.002237_bib7","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s11062-016-9559-9","article-title":"Posttraumatic stress disorder (PTSD): mechanisms and possible treatments","volume":"47","author":"Asalgoo","year":"2015","journal-title":"Neurophysiology"},{"key":"10.1124\/jpet.124.002237_bib8","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/FBP.0000000000000467","article-title":"Animal models of post-traumatic stress disorder and novel treatment targets","volume":"30","author":"Aspesi","year":"2019","journal-title":"Behav Pharmacol"},{"key":"10.1124\/jpet.124.002237_bib9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/YCO.0000000000000167","article-title":"Epidemiology of posttraumatic stress disorder: prevalence, correlates and consequences","volume":"28","author":"Atwoli","year":"2015","journal-title":"Curr Opin Psychiatry"},{"key":"10.1124\/jpet.124.002237_bib10","doi-asserted-by":"crossref","DOI":"10.1192\/bjo.2022.565","article-title":"Effects of psilocybin versus escitalopram on rumination and thought suppression in depression","volume":"8","author":"Barba","year":"2022","journal-title":"BJPsych Open"},{"key":"10.1124\/jpet.124.002237_bib11","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1124\/pr.118.015552","article-title":"International Union of Basic and Clinical Pharmacology. CX. Classification of receptors for 5-hydroxytryptamine; pharmacology and function","volume":"73","author":"Barnes","year":"2021","journal-title":"Pharmacol Rev"},{"key":"10.1124\/jpet.124.002237_bib12","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1038\/s41598-020-59282-y","article-title":"Emotions and brain function are altered up to one month after a single high dose of psilocybin","volume":"10","author":"Barrett","year":"2020","journal-title":"Sci Rep"},{"key":"10.1124\/jpet.124.002237_bib13","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1017\/S0033291715001981","article-title":"The epidemiology of traumatic event exposure worldwide: results from the World Mental Health Survey Consortium","volume":"46","author":"Benjet","year":"2016","journal-title":"Psychol Med"},{"key":"10.1124\/jpet.124.002237_bib14","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.copsyc.2017.01.003","article-title":"Pharmacological management of posttraumatic stress disorder","volume":"14","author":"Bernardy","year":"2017","journal-title":"Curr Opin Psychol"},{"issue":"Suppl 9","key":"10.1124\/jpet.124.002237_bib15","first-page":"12","article-title":"Posttraumatic stress disorder and comorbidity: recognizing the many faces of PTSD","volume":"58","author":"Brady","year":"1997","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1124\/jpet.124.002237_bib16","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.biopsych.2010.07.018","article-title":"The neural correlates of emotional memory in posttraumatic stress disorder","volume":"68","author":"Brohawn","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.1124\/jpet.124.002237_bib17","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1021\/acschemneuro.2c00718","article-title":"5-HT2ARs mediate therapeutic behavioral effects of psychedelic tryptamines","volume":"14","author":"Cameron","year":"2023","journal-title":"ACS Chem Neurosci"},{"issue":"Suppl 2","key":"10.1124\/jpet.124.002237_bib18","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1590\/1516-4446-2013-1139","article-title":"Animal models of anxiety disorders and stress","volume":"35","author":"Campos","year":"2013","journal-title":"Braz J Psychiatry"},{"key":"10.1124\/jpet.124.002237_bib19","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1126\/science.abl8615","article-title":"Structure-based discovery of nonhallucinogenic psychedelic analogs","volume":"375","author":"Cao","year":"2022","journal-title":"Science"},{"key":"10.1124\/jpet.124.002237_bib20","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa2032994","article-title":"Trial of psilocybin versus escitalopram for depression","volume":"384","author":"Carhart-Harris","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1124\/jpet.124.002237_bib21","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1038\/npp.2017.84","article-title":"The therapeutic potential of psychedelic drugs: past, present, and future","volume":"42","author":"Carhart-Harris","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.124.002237_bib22","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00213-017-4771-x","article-title":"Psilocybin with psychological support for treatment-resistant depression: six-month follow-up","volume":"235","author":"Carhart-Harris","year":"2018","journal-title":"Psychopharmacology"},{"key":"10.1124\/jpet.124.002237_bib23","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2215-0366(16)30065-7","article-title":"Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study","volume":"3","author":"Carhart-Harris","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1124\/jpet.124.002237_bib24","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00221-013-3579-0","article-title":"Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning","volume":"228","author":"Catlow","year":"2013","journal-title":"Exp Brain Res"},{"key":"10.1124\/jpet.124.002237_bib25","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s40501-024-00319-8","article-title":"Neurobiology of the antidepressant effects of serotonergic psychedelics: a narrative review","volume":"11","author":"Chisamore","year":"2024","journal-title":"Curr Treat Options Psych"},{"key":"10.1124\/jpet.124.002237_bib26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11920-020-1140-y","article-title":"Gender- and sex-based contributors to sex differences in PTSD","volume":"22","author":"Christiansen","year":"2020","journal-title":"Curr Psychiatry Rep"},{"key":"10.1124\/jpet.124.002237_bib27","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3389\/fpsyt.2020.00445","article-title":"The effects of individual psychotherapy in BDNF levels of patients with mental disorders: a systematic review","volume":"11","author":"Claudino","year":"2020","journal-title":"Front Psychiatry"},{"key":"10.1124\/jpet.124.002237_bib28","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/jts.22454","article-title":"ICD-11 posttraumatic stress disorder and complex posttraumatic stress disorder in the United States: a population-based study","volume":"32","author":"Cloitre","year":"2019","journal-title":"J\u00a0Trauma Stress"},{"key":"10.1124\/jpet.124.002237_bib29","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/da.20087","article-title":"Anxiolytic effect and memory improvement in rats by antisense oligodeoxynucleotide to 5-hydroxytryptamine-2A precursor protein","volume":"22","author":"Cohen","year":"2005","journal-title":"Depress Anxiety"},{"key":"10.1124\/jpet.124.002237_bib30","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF00401509","article-title":"A\u00a0possible correlation between drug-induced hallucinations in man and a behavioural response in mice","volume":"11","author":"Corne","year":"1967","journal-title":"Psychopharmacologia"},{"key":"10.1124\/jpet.124.002237_bib31","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/jamapsychiatry.2020.3285","article-title":"Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial","volume":"78","author":"Davis","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1124\/jpet.124.002237_bib32","article-title":"Increases in psychological flexibility mediate relationship between acute psychedelic effects and decreases in racial trauma symptoms among people of color","volume":"5","author":"Davis","year":"2021","journal-title":"Chronic Stress (Thousand Oaks)"},{"key":"10.1124\/jpet.124.002237_bib33","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1111\/ejn.14602","article-title":"The neurobiological basis of sex differences in learned fear and its inhibition","volume":"52","author":"Day","year":"2020","journal-title":"Eur J Neurosci"},{"key":"10.1124\/jpet.124.002237_bib34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrn.2016.155","article-title":"Stress, glucocorticoids and memory: implications for treating fear-related disorders","volume":"18","author":"de Quervain","year":"2017","journal-title":"Nat Rev"},{"key":"10.1124\/jpet.124.002237_bib35","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3390\/cells12060963","article-title":"Psychedelic targeting of metabotropic glutamate receptor 2 and its implications for the treatment of alcoholism","volume":"12","author":"Domanegg","year":"2023","journal-title":"Cells"},{"key":"10.1124\/jpet.124.002237_bib36","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/s41398-021-01706-y","article-title":"Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder","volume":"11","author":"Doss","year":"2021","journal-title":"Transl Psychiatry"},{"key":"10.1124\/jpet.124.002237_bib37","first-page":"2983","article-title":"Psilocybin facilitates fear extinction in mice by promoting hippocampal neuroplasticity","volume":"136","author":"Du","year":"2023","journal-title":"Chinese Med J (Engl)"},{"key":"10.1124\/jpet.124.002237_bib38","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.pnpbp.2008.10.005","article-title":"Reduced levels of NR2A and NR2B subunits of NMDA receptor and PSD-95 in the prefrontal cortex in major depression","volume":"33","author":"Feyissa","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1124\/jpet.124.002237_bib39","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/jts.20565","article-title":"A\u00a0guide to guidelines for the treatment of PTSD and related conditions","volume":"23","author":"Forbes","year":"2010","journal-title":"J\u00a0Trauma Stress"},{"key":"10.1124\/jpet.124.002237_bib40","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.biopsych.2007.07.009","article-title":"Frontolimbic serotonin 2A receptor binding in healthy subjects is associated with personality risk factors for affective disorder","volume":"63","author":"Frokjaer","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1124\/jpet.124.002237_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2024.01.001","article-title":"Effect of a single psilocybin treatment on Fos protein expression in male rat brain","volume":"539","author":"Funk","year":"2024","journal-title":"Neuroscience"},{"key":"10.1124\/jpet.124.002237_bib42","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1111\/jnc.16017","article-title":"Psilocybin as a lead candidate molecule in preclinical therapeutic studies of psychiatric disorders: a systematic review","volume":"168","author":"Gattuso","year":"2023","journal-title":"J\u00a0Neurochem"},{"key":"10.1124\/jpet.124.002237_bib43","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1021\/acschemneuro.8b00186","article-title":"DARK classics in chemical neuroscience: psilocybin","volume":"9","author":"Geiger","year":"2018","journal-title":"ACS Chem Neurosci"},{"key":"10.1124\/jpet.124.002237_bib44","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0893-133X(00)00136-6","article-title":"Behavioral evidence for interactions between a hallucinogenic drug and group II metabotropic glutamate receptors","volume":"23","author":"Gewirtz","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.124.002237_bib45","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1080\/14737175.2020.1826931","article-title":"The emerging role of psilocybin and MDMA in the treatment of mental illness","volume":"20","author":"Gill","year":"2020","journal-title":"Expert Rev Neurother"},{"key":"10.1124\/jpet.124.002237_bib46","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1021\/acsptsci.2c00177","article-title":"Structure-activity relationships for psilocybin, baeocystin, aeruginascin, and related analogues to produce pharmacological effects in mice","volume":"5","author":"Glatfelter","year":"2022","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10.1124\/jpet.124.002237_bib47","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nature06612","article-title":"Identification of a serotonin\/glutamate receptor complex implicated in psychosis","volume":"452","author":"Gonzalez-Maeso","year":"2008","journal-title":"Nature"},{"key":"10.1124\/jpet.124.002237_bib48","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.neuron.2007.01.008","article-title":"Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior","volume":"53","author":"Gonzalez-Maeso","year":"2007","journal-title":"Neuron"},{"key":"10.1124\/jpet.124.002237_bib49","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","article-title":"Single-dose psilocybin for a treatment-resistant episode of major depression","volume":"387","author":"Goodwin","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1124\/jpet.124.002237_bib50","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jad.2023.01.108","article-title":"Single-dose psilocybin for a treatment-resistant episode of major depression: impact on patient-reported depression severity, anxiety, function, and quality of life","volume":"327","author":"Goodwin","year":"2023","journal-title":"J\u00a0Affect Disord"},{"key":"10.1124\/jpet.124.002237_bib51","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1124\/jpet.124.002237_bib52","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archgenpsychiatry.2010.116","article-title":"Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer","volume":"68","author":"Grob","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"10.1124\/jpet.124.002237_bib53","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1177\/1363461520983684","article-title":"Psychedelics, placebo effects, and set and setting: insights from common factors theory of psychotherapy","volume":"59","author":"Gukasyan","year":"2022","journal-title":"Transcult Psychiatry"},{"key":"10.1124\/jpet.124.002237_bib54","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/7854_2016_466","article-title":"Effect of hallucinogens on unconditioned behavior","volume":"36","author":"Halberstadt","year":"2018","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1124\/jpet.124.002237_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107933","article-title":"Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species","volume":"167","author":"Halberstadt","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.124.002237_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.109686","article-title":"Psilocybin induces acute anxiety and changes in amygdalar phosphopeptides independently from the 5-HT2A receptor","volume":"27","author":"Harari","year":"2024","journal-title":"iScience"},{"key":"10.1124\/jpet.124.002237_bib57","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2022489118","article-title":"Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice","volume":"118","author":"Hesselgrave","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/jpet.124.002237_bib58","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1021\/acschemneuro.9b00493","article-title":"Psychedelics, but not ketamine, produce persistent antidepressant-like effects in a rodent experimental system for the study of depression","volume":"11","author":"Hibicke","year":"2020","journal-title":"ACS Chem Neurosci"},{"key":"10.1124\/jpet.124.002237_bib59","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/j.neubiorev.2012.07.001","article-title":"Neurobiology of chronic mild stress: parallels to major depression","volume":"36","author":"Hill","year":"2012","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1124\/jpet.124.002237_bib60","series-title":"Chemical Constitution and Pharmacodynamic Actions","article-title":"Psychotomimetic agents","author":"Hofmann","year":"1968"},{"key":"10.1124\/jpet.124.002237_bib61","series-title":"LSD: My Problem Child","author":"Hofmann","year":"1980"},{"key":"10.1124\/jpet.124.002237_bib62","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/s41467-019-09562-7","article-title":"Lower synaptic density is associated with depression severity and network alterations","volume":"10","author":"Holmes","year":"2019","journal-title":"Nat Commun"},{"key":"10.1124\/jpet.124.002237_bib63","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.cobeha.2018.01.016","article-title":"Brain mechanisms mediating effects of stress on reward sensitivity","volume":"22","author":"Ironside","year":"2018","journal-title":"Curr Opin Behav Sci"},{"key":"10.1124\/jpet.124.002237_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2022.136836","article-title":"Differences across sexes on head-twitch behavior and 5-HT(2A) receptor signaling in C57BL\/6J mice","volume":"788","author":"Jaster","year":"2022","journal-title":"Neurosci Lett"},{"key":"10.1124\/jpet.124.002237_bib65","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1177\/0269881120959614","article-title":"Transcriptional regulation in the rat prefrontal cortex and hippocampus after a single administration of psilocybin","volume":"35","author":"Jefsen","year":"2021","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1124\/jpet.124.002237_bib66","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1021\/acsptsci.3c00123","article-title":"Transient elevation of plasma glucocorticoids supports psilocybin-induced anxiolysis in mice","volume":"6","author":"Jones","year":"2023","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10.1124\/jpet.124.002237_bib67","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/nm.2886","article-title":"Decreased expression of synapse-related genes and loss of synapses in major depressive disorder","volume":"18","author":"Kang","year":"2012","journal-title":"Nat Med"},{"key":"10.1124\/jpet.124.002237_bib68","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1074\/mcp.M113.036558","article-title":"Quantitative phosphoproteomics unravels biased phosphorylation of serotonin 2A receptor at Ser280 by hallucinogenic versus nonhallucinogenic agonists","volume":"13","author":"Karaki","year":"2014","journal-title":"Mol Cell Proteomics"},{"key":"10.1124\/jpet.124.002237_bib69","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/7854_2022_366","article-title":"Psilocybin for trauma-related disorders","volume":"56","author":"Khan","year":"2022","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1124\/jpet.124.002237_bib70","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1038\/s41380-023-02280-z","article-title":"Repeated low doses of psilocybin increase resilience to stress, lower compulsive actions, and strengthen cortical connections to the paraventricular thalamic nucleus in rats","volume":"28","author":"Kiilerich","year":"2023","journal-title":"Mol Psychiatry"},{"key":"10.1124\/jpet.124.002237_bib71","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jad.2022.09.168","article-title":"Psychedelic therapy for depressive symptoms: a systematic review and meta-analysis","volume":"322","author":"Ko","year":"2023","journal-title":"J\u00a0Affect Disord"},{"key":"10.1124\/jpet.124.002237_bib72","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/ijnp\/pyaa018","article-title":"Reviewing the potential of psychedelics for the treatment of PTSD","volume":"23","author":"Krediet","year":"2020","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1124\/jpet.124.002237_bib73","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s11920-017-0829-z","article-title":"Synaptic loss and the pathophysiology of PTSD: implications for ketamine as a prototype novel therapeutic","volume":"19","author":"Krystal","year":"2017","journal-title":"Curr Psychiatry Rep"},{"key":"10.1124\/jpet.124.002237_bib74","article-title":"Psychedelic drugs in the treatment of anxiety, depression and addiction","volume":"138","author":"Kvam","year":"2018","journal-title":"Tidsskr Nor Laegeforen"},{"key":"10.1124\/jpet.124.002237_bib75","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/s41593-022-01177-4","article-title":"The neural basis of psychedelic action","volume":"25","author":"Kwan","year":"2022","journal-title":"Nat Neurosci"},{"key":"10.1124\/jpet.124.002237_bib76","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1038\/sj.npp.1300944","article-title":"Hallucinogen-induced UP states in the brain slice of rat prefrontal cortex: role of glutamate spillover and NR2B-NMDA receptors","volume":"31","author":"Lambe","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"Suppl 1","key":"10.1124\/jpet.124.002237_bib77","first-page":"49","article-title":"Posttraumatic stress disorder in primary care: a hidden diagnosis","volume":"65","author":"Lecrubier","year":"2004","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1124\/jpet.124.002237_bib78","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40263-021-00877-y","article-title":"Molecular mechanisms of psilocybin and implications for the treatment of depression","volume":"36","author":"Ling","year":"2022","journal-title":"CNS Drugs"},{"key":"10.1124\/jpet.124.002237_bib79","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.ijpsycho.2014.11.006","article-title":"Learning models of PTSD: Theoretical accounts and psychobiological evidence","volume":"98","author":"Lissek","year":"2015","journal-title":"Int J Psychophysiol"},{"key":"10.1124\/jpet.124.002237_bib80","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.biopsych.2015.01.011","article-title":"Chronic stress induces brain region-specific alterations of molecular rhythms that correlate with depression-like behavior in mice","volume":"78","author":"Logan","year":"2015","journal-title":"Biol Psychiatry"},{"key":"10.1124\/jpet.124.002237_bib81","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/7854_2017_478","article-title":"Hallucinogens and serotonin 5-HT(2A) receptor-mediated signaling pathways","volume":"36","author":"Lopez-Gimenez","year":"2018","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1124\/jpet.124.002237_bib82","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.3390\/molecules27082520","article-title":"Psychedelics: alternative and potential therapeutic options for treating mood and anxiety disorders","volume":"27","author":"Lowe","year":"2022","journal-title":"Molecules"},{"key":"10.1124\/jpet.124.002237_bib83","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.yfrne.2018.02.001","article-title":"The effects of chronic stress on the human brain: From neurotoxicity, to vulnerability, to opportunity","volume":"49","author":"Lupien","year":"2018","journal-title":"Front Neuroendocrinol"},{"key":"10.1124\/jpet.124.002237_bib84","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","article-title":"Psychedelics promote structural and functional neural plasticity","volume":"23","author":"Ly","year":"2018","journal-title":"Cell Rep"},{"key":"10.1124\/jpet.124.002237_bib85","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.euroneuro.2021.06.001","article-title":"Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience","volume":"50","author":"Madsen","year":"2021","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1124\/jpet.124.002237_bib86","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.phrs.2019.02.001","article-title":"Recent advances in the neurobiology of posttraumatic stress disorder: A review of possible mechanisms underlying an effective pharmacotherapy","volume":"142","author":"Malikowska-Racia","year":"2019","journal-title":"Pharmacol Res"},{"key":"10.1124\/jpet.124.002237_bib87","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3389\/fphar.2018.00256","article-title":"Individual experiences in four cancer patients following psilocybin-assisted psychotherapy","volume":"9","author":"Malone","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1124\/jpet.124.002237_bib88","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1038\/s41386-020-0718-8","article-title":"Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin","volume":"45","author":"Mason","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.124.002237_bib89","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cmet.2023.12.022","article-title":"The hormesis principle of neuroplasticity and neuroprotection","volume":"36","author":"Mattson","year":"2024","journal-title":"Cell Metab"},{"key":"10.1124\/jpet.124.002237_bib90","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s11414-011-9263-x","article-title":"Discrepancy in diagnosis and treatment of post-traumatic stress disorder (PTSD): treatment for the wrong reason","volume":"39","author":"Meltzer","year":"2011","journal-title":"J\u00a0Behav Health Serv Res"},{"key":"10.1124\/jpet.124.002237_bib91","unstructured":"Miller CE, Naylor MM, Del Valle CR, Sparkman HR, Bramlage BE, Puppel LP, Brown ML, Al-Olimat AK, King KM, Savini MJ, et\u00a0al. (2023) Low-dose psilocybin sex-dependently enhances fear extinction in adult rats, in Annual Meeting of the Society for Neuroscience; 2024 Apr 16\u201319; Washington, DC, 49, ONU Student Research Colloquium."},{"key":"10.1124\/jpet.124.002237_bib92","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/mp.2013.105","article-title":"Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N=9484)","volume":"19","author":"Molendijk","year":"2014","journal-title":"Mol Psychiatry"},{"key":"10.1124\/jpet.124.002237_bib93","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/s41593-023-01316-5","article-title":"Psychedelics promote plasticity by directly binding to BDNF receptor TrkB","volume":"26","author":"Moliner","year":"2023","journal-title":"Nat Neurosci"},{"key":"10.1124\/jpet.124.002237_bib94","series-title":"The Social Environment and Depression: The Roles of Life Stress","year":"2014"},{"key":"10.1124\/jpet.124.002237_bib95","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.neulet.2011.01.046","article-title":"Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists","volume":"493","author":"Moreno","year":"2011","journal-title":"Neurosci Lett"},{"key":"10.1124\/jpet.124.002237_bib96","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1089\/psymed.2022.0002","article-title":"A\u00a0Bayesian reanalysis of a trial of psilocybin versus escitalopram for depression","volume":"1","author":"Nayak","year":"2023","journal-title":"Psychedelic Med (New Rochelle)"},{"key":"10.1124\/jpet.124.002237_bib97","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/da.22738","article-title":"Impaired neuroplasticity in the prefrontal cortex in depression indexed through paired associative stimulation","volume":"35","author":"Noda","year":"2018","journal-title":"Depress Anxiety"},{"key":"10.1124\/jpet.124.002237_bib98","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.227","article-title":"Brain-derived neurotrophic factor increase during treatment in severe mental illness inpatients","volume":"6","author":"Nuernberg","year":"2016","journal-title":"Transl Psychiatry"},{"key":"10.1124\/jpet.124.002237_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.113093","article-title":"Investigating the role of 5-HT2A and 5-HT2C receptor activation in the effects of psilocybin, DOI, and citalopram on marble burying in mice","volume":"401","author":"Odland","year":"2021","journal-title":"Behav Brain Res"},{"key":"10.1124\/jpet.124.002237_bib100","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1001\/jama.2018.19290","article-title":"Management of Posttraumatic Stress Disorder","volume":"321","author":"Ostacher","year":"2019","journal-title":"JAMA"},{"key":"10.1124\/jpet.124.002237_bib101","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.pnpbp.2010.02.008","article-title":"Sex differences in the effects of N,N-diethyllysergamide (LSD) on behavioural activity and prepulse inhibition","volume":"34","author":"Palenicek","year":"2010","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1124\/jpet.124.002237_bib102","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrn3379","article-title":"Neurotrophin regulation of neural circuit development and function","volume":"14","author":"Park","year":"2013","journal-title":"Nat Rev"},{"key":"10.1124\/jpet.124.002237_bib103","first-page":"127","article-title":"BDNF as a biomarker in diagnosis and evaluation of treatment for schizophrenia and depression","volume":"26","author":"Peng","year":"2018","journal-title":"Discov Med"},{"key":"10.1124\/jpet.124.002237_bib104","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.copsyc.2016.11.002","article-title":"Gender and PTSD: different pathways to a similar phenotype","volume":"14","author":"Pineles","year":"2017","journal-title":"Curr Opin Psychol"},{"key":"10.1124\/jpet.124.002237_bib105","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/jama.2023.14530","article-title":"Single-dose psilocybin treatment for major depressive disorder: a randomized clinical trial","volume":"330","author":"Raison","year":"2023","journal-title":"JAMA"},{"key":"10.1124\/jpet.124.002237_bib106","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1001\/jamapsychiatry.2018.3412","article-title":"Efficacy of prolonged exposure therapy, sertraline hydrochloride, and their combination among combat veterans with posttraumatic stress disorder: a randomized clinical trial","volume":"76","author":"Rauch","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1124\/jpet.124.002237_bib107","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3389\/fnhum.2014.00204","article-title":"The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers","volume":"8","author":"Roseman","year":"2014","journal-title":"Front Hum Neurosci"},{"key":"10.1124\/jpet.124.002237_bib108","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3389\/fphar.2017.00974","article-title":"Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression","volume":"8","author":"Roseman","year":"2017","journal-title":"Front Pharmacol"},{"key":"10.1124\/jpet.124.002237_bib109","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.medj.2024.01.005","article-title":"Psilocybin-assisted psychotherapy for treatment resistant depression: a randomized clinical trial evaluating repeated doses of psilocybin","volume":"5","author":"Rosenblat","year":"2024","journal-title":"Med"},{"key":"10.1124\/jpet.124.002237_bib110","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1021\/acsptsci.1c00020","article-title":"Acute and sustained reductions in loss of meaning and suicidal ideation following psilocybin-assisted psychotherapy for psychiatric and existential distress in life-threatening cancer","volume":"4","author":"Ross","year":"2021","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10.1124\/jpet.124.002237_bib111","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1177\/0269881116675512","article-title":"Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial","volume":"30","author":"Ross","year":"2016","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1124\/jpet.124.002237_bib112","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.biopsych.2008.05.005","article-title":"Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications","volume":"64","author":"Sen","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1124\/jpet.124.002237_bib113","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1016\/j.neuron.2021.06.008","article-title":"Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in\u00a0vivo","volume":"109","author":"Shao","year":"2021","journal-title":"Neuron"},{"key":"10.1124\/jpet.124.002237_bib114","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jpsychires.2021.05.019","article-title":"Registered clinical studies investigating psychedelic drugs for psychiatric disorders","volume":"139","author":"Siegel","year":"2021","journal-title":"J\u00a0Psychiatric Res"},{"key":"10.1124\/jpet.124.002237_bib115","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/s41398-023-02456-9","article-title":"Effect of psilocybin on marble burying in ICR mice: role of 5-HT1A receptors and implications for the treatment of obsessive-compulsive disorder","volume":"13","author":"Singh","year":"2023","journal-title":"Transl Psychiatry"},{"key":"10.1124\/jpet.124.002237_bib116","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1177\/02698811231154852","article-title":"Psilocybin-assisted therapy for major depressive disorder: an exploratory placebo-controlled, fixed-order trial","volume":"37","author":"Sloshower","year":"2023","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1124\/jpet.124.002237_bib117","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1021\/acsptsci.0c00169","article-title":"Psilocybin-assisted group therapy and attachment: observed reduction in attachment anxiety and influences of attachment insecurity on the psilocybin experience","volume":"4","author":"Stauffer","year":"2021","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10.1124\/jpet.124.002237_bib118","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1177\/0269881110382466","article-title":"Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies","volume":"25","author":"Studerus","year":"2011","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1124\/jpet.124.002237_bib119","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1007\/s00210-023-02778-x","article-title":"Ethopharmacological evaluation of antidepressant-like effect of serotonergic psychedelics in C57BL\/6J male mice","volume":"397","author":"Takaba","year":"2023","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/jpet.124.002237_bib120","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2174\/187152707780363276","article-title":"Targeting neurotrophic\/growth factor expression and signaling for antidepressant drug development","volume":"6","author":"Tanis","year":"2007","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1124\/jpet.124.002237_bib121","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.neuint.2009.06.013","article-title":"BDNF downregulates 5-HT(2A) receptor protein levels in hippocampal cultures","volume":"55","author":"Trajkovska","year":"2009","journal-title":"Neurochem Int"},{"key":"10.1124\/jpet.124.002237_bib122","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/FBP.0000000000000198","article-title":"Sex differences and serotonergic mechanisms in the behavioural effects of psilocin","volume":"27","author":"Tyls","year":"2016","journal-title":"Behav Pharmacol"},{"key":"10.1124\/jpet.124.002237_bib123","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1523\/JNEUROSCI.17-08-02785.1997","article-title":"5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex","volume":"17","author":"Vaidya","year":"1997","journal-title":"J\u00a0Neurosci"},{"key":"10.1124\/jpet.124.002237_bib124","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.nlm.2013.11.014","article-title":"From Pavlov to PTSD: the extinction of conditioned fear in rodents, humans, and anxiety disorders","volume":"113","author":"VanElzakker","year":"2014","journal-title":"Neurobiol Learn Mem"},{"key":"10.1124\/jpet.124.002237_bib125","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1126\/science.adf0435","article-title":"Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors","volume":"379","author":"Vargas","year":"2023","journal-title":"Science"},{"key":"10.1124\/jpet.124.002237_bib126","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/02791072.2020.1817639","article-title":"Efficacy of psychoactive drugs for the treatment of posttraumatic stress disorder: a systematic review of MDMA, ketamine, LSD and psilocybin","volume":"53","author":"Varker","year":"2021","journal-title":"J\u00a0Psychoactive Drugs"},{"key":"10.1124\/jpet.124.002237_bib127","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nrn2884","article-title":"The neurobiology of psychedelic drugs: implications for the treatment of mood disorders","volume":"11","author":"Vollenweider","year":"2010","journal-title":"Nat Rev"},{"key":"10.1124\/jpet.124.002237_bib128","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41583-020-0367-2","article-title":"Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders","volume":"21","author":"Vollenweider","year":"2020","journal-title":"Nat Rev"},{"key":"10.1124\/jpet.124.002237_bib129","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1097\/00001756-199812010-00024","article-title":"Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action","volume":"9","author":"Vollenweider","year":"1998","journal-title":"Neuroreport"},{"key":"10.1124\/jpet.124.002237_bib130","article-title":"Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial","volume":"56","author":"von Rotz","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1124\/jpet.124.002237_bib131","doi-asserted-by":"crossref","first-page":"8221","DOI":"10.1038\/s41467-023-44016-1","article-title":"Identification of 5-HT(2A) receptor signaling pathways associated with psychedelic potential","volume":"14","author":"Wallach","year":"2023","journal-title":"Nat Commun"},{"key":"10.1124\/jpet.124.002237_bib132","first-page":"520","article-title":"Patients\u2019 accounts of increased \u201cconnectedness\u201d and \u201cacceptance\u201d after psilocybin for treatment-resistant depression","volume":"57","author":"Watts","year":"2017","journal-title":"J\u00a0Hum Psychol"},{"key":"10.1124\/jpet.124.002237_bib133","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1126\/science.1123432","article-title":"Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice","volume":"313","author":"Weisstaub","year":"2006","journal-title":"Science"},{"key":"10.1124\/jpet.124.002237_bib134","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1021\/acschemneuro.4c00279","article-title":"Psilocybin facilitate fear extinction: importance of dose, context, and serotonin receptors","volume":"15","author":"Woodburn","year":"2024","journal-title":"ACS Chem Neurosci"},{"key":"10.1124\/jpet.124.002237_bib135","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1007\/s43440-023-00539-4","article-title":"Cardiovascular safety of psychedelic medicine: current status and future directions","volume":"75","author":"Wsol","year":"2023","journal-title":"Pharmacol Rep"},{"key":"10.1124\/jpet.124.002237_bib136","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ynstr.2015.07.002","article-title":"BA11 FKBP5 expression levels correlate with dendritic spine density in postmortem PTSD and controls","volume":"2","author":"Young","year":"2015","journal-title":"Neurobiol Stress"},{"key":"10.1124\/jpet.124.002237_bib137","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.pnpbp.2007.07.009","article-title":"AMPA receptor involvement in 5-hydroxytryptamine2A receptor-mediated pre-frontal cortical excitatory synaptic currents and DOI-induced head shakes","volume":"32","author":"Zhang","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1124\/jpet.124.002237_bib138","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1177\/02698811241249436","article-title":"Psilocybin promotes neuroplasticity and induces rapid and sustained antidepressant-like effects in mice","volume":"38","author":"Zhao","year":"2024","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1124\/jpet.124.002237_bib139","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/17460441.2020.1820982","article-title":"Animal models for the discovery of novel drugs for post-traumatic stress disorder","volume":"16","author":"Zoladz","year":"2020","journal-title":"Expert Opin Drug Discov"},{"key":"10.1124\/jpet.124.002237_bib140","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.neubiorev.2013.03.024","article-title":"Current status on behavioral and biological markers of PTSD: a search for clarity in a conflicting literature","volume":"37","author":"Zoladz","year":"2013","journal-title":"Neurosci Biobehav Rev"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524000843?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524000843?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.124.002237","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T18:11:07Z","timestamp":1738260667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524000843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":140,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0022356524000843"],"URL":"https:\/\/doi.org\/10.1124\/jpet.124.002237","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the potential for psilocybin as a treatment for post-traumatic stress disorder","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.124.002237","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100026"}}